Progress report on GENVEC's HATH1 patent:
From freepatentsonline.com:
Title: ADENOVIRAL VECTOR ENCODING HUMAN ATONAL HOMOLOG-1 (HATH1)
Document Type and Number: United States Patent Application 0160102320
Kind Code: A1
Abstract: The invention is directed to a replication-deficient adenoviral vector comprising a nucleic acid sequence encoding a human atonal homolog-1 (Hath1) protein operably linked to a human glial fibrillary acidic protein (GFAP) promoter. The invention also is directed to a composition and method utilizing the adenoviral vector to generate sensory cells in the inner ear of a human.
Inventors: Brough, Douglas E. (Gaithersburg, MD, US)
Ettyreddy, Damodar R. (Clarksburg, MD, US)
Application Number: 14/879318
Publication Date: 4/14/2016
Filing Date: 10/09/2015
----
From The Business of Patents:
The publication of a patent application marks the date at which it is publicly available and therefore at which it forms full prior art for other patent applications worldwide.
It should be understood that a publication is still an application - and cannot be enforced as an issued patent in terms of infringement.
There are some potential monetary advantages to this. In exchange for publication of a patent application, patentees may be able to obtain a reasonable royalty during the period beginning on the date of publication of the application.
